Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.
about
The group A streptococcal collagen-like protein-1, Scl1, mediates biofilm formation by targeting the extra domain A-containing variant of cellular fibronectin expressed in wounded tissueCorrelates of Protection for M Protein-Based Vaccines against Group A StreptococcusThe crystal structure of the streptococcal collagen-like protein 2 globular domain from invasive M3-type group A Streptococcus shows significant similarity to immunomodulatory HIV protein gp41Genome-wide analyses of small non-coding RNAs in streptococciStreptococcus pyogenes biofilms-formation, biology, and clinical relevanceInvasive group A streptococcal infection and vaccine implications, Auckland, New ZealandRelationships between emm and multilocus sequence types within a global collection of Streptococcus pyogenes.Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infectionThe classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design.Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroadsProgress in the development of effective vaccines to prevent selected gram-positive bacterial infections.StreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice.Group A streptococcus expresses a trio of surface proteins containing protective epitopes.Epidemiology of invasive Streptococcus pyogenes infections in France in 2007Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010.tRNA modification by GidA/MnmE is necessary for Streptococcus pyogenes virulence: a new strategy to make live attenuated strains.Streptococcus pyogenes Employs Strain-dependent Mechanisms of C3b Inactivation to Inhibit Phagocytosis and Killing of Bacteria.Mode of expression and functional characterization of FCT-3 pilus region-encoded proteins in Streptococcus pyogenes serotype M49.Reduced thrombin generation increases host susceptibility to group A streptococcal infectionA novel integrative conjugative element mediates genetic transfer from group G Streptococcus to other {beta}-hemolytic StreptococciProspective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007.Population biology of the human restricted pathogen, Streptococcus pyogenes.A decade of molecular pathogenomic analysis of group A Streptococcus.Novel strategies for controlling Streptococcus pyogenes infection and associated diseases: from potential peptide vaccines to antibody immunotherapy.Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.Prevention and treatment of rheumatic heart disease in the developing world.Rheumatic heart disease and its control in the Pacific.Invasive group a streptococcal disease: epidemiology, pathogenesis and management.Vaccination against rheumatic heart disease: a review of current research strategies and challenges.Development of Group A streptococcal vaccines: an unmet global health need.Streptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines.Streptococcus pyogenes serotype-dependent and independent changes in infected HEp-2 epithelial cells.Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.Historical aspects of rheumatic fever.Immunogenicity of a divalent group A streptococcal vaccine.Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.A structural overview of mycobacterial adhesins: Key biomarkers for diagnostics and therapeutics.
P2860
Q23913488-6CFCC428-0D3F-48D9-BD01-32239B65CCE5Q27009175-C6AE3C5C-69F6-4E6B-92AC-F70B8D6F8752Q27680983-9F6F54F0-B6C1-497A-AA67-DF393B8FAF92Q28085500-3BD6B658-1822-47D9-9720-15E27E4E7FBEQ28387682-0F55486E-ADDF-4760-B5AF-B07B1AD3E002Q28729759-0C4C6C4D-7347-4C9F-9BC3-39D1507982E9Q30481807-88350134-4918-4DC3-A470-6DAB751DB2D0Q33778264-F63080D3-4182-4EB1-865C-D9CB9EE055A1Q33832084-D2F8F2D8-79F0-4C5F-BCB4-F57F2B90C7F3Q33916408-93446E9A-8917-4348-8E91-348AC73083DCQ34112608-5AE862E1-1789-489C-9534-D2EB96CE941FQ34674395-0C39B934-468F-4EE7-A4DD-450E9E64629FQ34701389-87FDB4D1-51DB-482D-B852-95E0F82BA550Q35598886-F60D3362-0DED-4E5B-9B3B-1A874089C6B7Q35847191-AE5B81AA-87D9-4105-B400-2AB14C9DCA24Q36747212-6C81A09F-E80A-4586-AAE3-A7ED5625F5BAQ36884841-D96978CB-D122-4110-9394-52E57AC729C0Q37033026-33C0C483-DD49-4DFD-B1EB-FF455B0E06D9Q37086949-DCB620B4-4DC1-4A7E-B8B6-B114F5A02AB4Q37127804-055DC180-DCA0-476E-8489-70ABF7A073E3Q37133260-C605DA48-315B-4DC3-8F4A-6668D09EF339Q37201383-F26D928F-1958-421A-8E73-D60436F24593Q37328487-0399DDD7-AA25-44DD-A0F2-9DAAE9F20332Q37471470-72B5905B-2616-4EA4-9541-2C013337BEEDQ37478261-CD124441-CFB7-4228-A9A7-8FCDA7CB78F0Q37596966-90A8A6E9-F684-4CC9-940C-B4F5BBC97D2CQ37642819-A05BE070-989A-4300-9CF8-93F1597AECA0Q38017734-3C67200A-0779-4045-A878-CFD44314138EQ38021366-A969BB70-2364-47BC-B704-CBB42FF85AF2Q38631048-27F1F4AE-81DA-4A63-A170-AEBF53C7A9D9Q39975371-D3F9E081-D706-4187-A036-980AC2FD0665Q40039582-BDB9B3AA-A0BD-4400-83F3-423497FDEC28Q40068749-1CB3D609-CF96-46C3-90DD-21F848958BD4Q40173912-CA83BFAE-0325-424F-ACF2-CAE42AEF9493Q40278264-58CBE138-AF33-4CCD-B1C7-C77131893D7BQ42249041-57B885B9-49C7-403C-95C7-3468819F7C69Q47400831-C0402AEC-1B9D-4BED-9D87-39321113EE54
P2860
Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Prospects for a group A strept ...... Infectious Diseases workshop.
@ast
Prospects for a group A strept ...... Infectious Diseases workshop.
@en
type
label
Prospects for a group A strept ...... Infectious Diseases workshop.
@ast
Prospects for a group A strept ...... Infectious Diseases workshop.
@en
prefLabel
Prospects for a group A strept ...... Infectious Diseases workshop.
@ast
Prospects for a group A strept ...... Infectious Diseases workshop.
@en
P2093
P2860
P356
P1476
Prospects for a group A strept ...... d Infectious Diseases workshop
@en
P2093
Alan L Bisno
Fran A Rubin
National Institute of Allergy and Infectious Diseases
P Patrick Cleary
P2860
P304
P356
10.1086/444505
P407
P50
P577
2005-09-02T00:00:00Z